GE Healthcare (Chalfont St. Giles, UK) announced the Brivo NM615 has received clearance from the US Food and Drug Administration (FDA). An advanced single head nuclear medicine gamma camera with SPECT capability, the system gives clinicians the ability to lower injected patient dose by as much as 50% of those of conventional nuclear medicine scanning protocols, or the potential for patients to spend considerably less time on the table during exams, without compromising image quality. Made possible through GE’s novel detector design and Evolution technology, this single head system has the ability to achieve shortened scan times similar to a dual-head system. (Shorter acquisition times and dose reduction capabilities are possible with the Brivo NM615 system only when used in combination with the relevant features offered on the Xeleris 3 processing and review workstation.)

“We are proud to continue offering new nuclear medicine solutions allowing our customers to expand patient care across a wide range of capabilities and budgets,” said Nathan Hermony, global GM of nuclear medicine, GE Healthcare. “Our investments in advanced technologies such as the redesigned Elite NXT detector in the NM600 product family and the solid-state CZT [cadmium zinc telluride] detector in the NM500 product family are designed to help clinicians make life-saving decisions for their patients, more confidently.”

GE Healthcare Brivo NM615 is designed to help accommodate more patients than earlier generation GE nuclear medicine systems. With its large 70-cm wide bore and table capable of handling patients up to 227 kg, the system provides access to a wide range of patient sizes. Brivo NM615 can also be upgraded on site to the GE Healthcare Discovery NM630 or the Discovery NM/CT 670 SPECT/computed tomography (CT) hybrid systems through on-site hardware changes. As a result, Brivo NM615 may protect the initial investment by expanding the ability to serve patients well into the future at even faster speeds and with SPECT/ CT hybrid scanning capability.

A step forward in detector design, the Elite NXT detector enables exceptional image quality. Elite NXT detectors are designed to offer remarkable SPECT resolution and contrast for excellent image quality, all to help clinicians diagnose patients early and effectively. Ultrathin design and auto-body contouring minimize the distance between the patient and the detectors for excellent resolution while SPECT-optimized collimators and the very high count rate enable extremely precise event detection.

In institutions and centers with high patient volumes, Brivo NM615 may provide a cost-effective way to help clinicians increase capacity without compromising image quality; and due to the simple upgrade path, physicians facing budget limits can choose the solution that meets their needs now and know that as their needs change, their system can also evolve.

Brivo NM615 can be used with the advanced Xeleris workstation, which incorporates new and existing nuclear medicine equipment, including legacy GE and non-GE devices, and is designed to provide consistent results and enhanced workflow. Xeleris can keep clinicians connected to images and applications from picture archiving and communication system (PACS) and personal computers (PCs) within their institution and remotely.

Related Links:
GE Healthcare